IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Theravance Inc

CUSIP: 88338T954 | 6 institutional holders

Quarters

Q4 2015Q3 2015Q2 2015Q1 2015Q4 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile